Content deleted Content added
No edit summary |
Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 |
||
(52 intermediate revisions by 35 users not shown) | |||
Line 1:
{{Short description|Topical gel}}
{{Drugbox
| verifiedrevid = 447540026
<!--Combo data-->
| type = combo
| component1 = Erythromycin
| class1 = [[Macrolide]] [[antibiotic]]
| component2 = Isotretinoin
| class2 = [[Retinoid]]
<!--Clinical data-->
| tradename = Isotrexin
| Drugs.com = {{drugs.com|UK|isotrexin-gel-spc-3886}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = Topical gel
<!--Identifiers-->
| CAS_number = 527736-87-4
| ATCvet =
| ATC_prefix = D10
| ATC_suffix = AD54
| PubChem =
<!--Chemical data-->
}}
'''Erythromycin/isotretinoin''' (trade name '''Isotrexin''') is a [[Topical medication|topical]] gel with two active ingredients: [[erythromycin]] 2% [[w/w]] and [[isotretinoin]] 0.05% w/w with a primary indication for the treatment of moderate [[acne vulgaris]].<ref name=":0">{{Cite web|url=http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1396241880421.pdf|title=Isotrexin Gel (isotretinoin 0.05%/erythromycin 2%)|date=|website=mhra.gov.uk|publisher=Stiefel Laboratories Ltd.|access-date=|archive-date=2017-01-22|archive-url=https://web.archive.org/web/20170122155315/http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1396241880421.pdf|url-status=dead}}</ref><ref>{{Cite web | vauthors = Marshall H | date = 10 May 2017 |url=http://www.netdoctor.co.uk/medicines/skin-and-hair/a6936/isotrexin-gel-isotretinoin-erythromycin/|title=Isotrexin gel (isotretinoin, erythromycin) |website=Netdoctor|access-date=2016-05-10}}</ref>
Isotretinoin is a pharmaceutical derivative of [[retinoic acid]] (a metabolite of vitamin A). Its mechanism of action is believed to involve reduction in the amount of [[sebum]] produced by [[sebaceous gland]]s on the skin's surface.
Erythromycin is a [[Bacteriostatic agent|bacteriostatic]] [[macrolide]] antibiotic used to treat bacterial infections, including the inhibition of bacteria linked with acne, such ''[[Cutibacterium acnes]]''. The mechanism of action is poorly understood.<ref>{{cite journal | vauthors = Giannopoulos L, Papaparaskevas J, Refene E, Daikos G, Stavrianeas N, Tsakris A | title = MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris | journal = Anaerobe | volume = 31 | pages = 50–54 | date = February 2015 | pmid = 25451716 | doi = 10.1016/j.anaerobe.2014.10.007 | series = Special Issue: Antibiotic resistance of anaerobic bacteria }}</ref>
== Side effects ==
Erythromycin/isotretinoin may cause a number of [[side effect]]s, ranging from very common to rare. Most side effects affect the skin and have only a local effect to the place of application. Some of the side effects are related to [[Hypervitaminosis A|vitamin A toxicity]].<ref name=":0" />
{| class="wikitable"
!Very common (≥ 1/10)
!Common (≥ 1/100, < 1/10)
!Unknown frequency
|-
|Skin pain
|[[Dermatitis]]
|[[Allergy|Allergic reaction]]
|-
|Rash
|
|Facial swelling
|-
|[[Xeroderma]] (dry skin)
|
|[[Urticaria|Hives]]
|-
|[[Itch|Prunitis]] (skin itching)
|
|Abdominal pain
|-
|Skin burning sensation
|
|Diarrhea
|-
|[[Erythema|Erythematous]] (skin redness)
|
|Skin [[Photodermatitis|photosensitivity]]
|-
|Skin irritation
|
|Skin discoloration
|-
|Skin peeling or scaling
|
|
|}
== References ==
{{Reflist}}
{{Acne agents}}
{{DEFAULTSORT:Erythromycin isotretinoin}}
[[Category:Anti-acne preparations]]
[[Category:Combination drugs]]
[[Category:Isotretinoin]]
|